These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 3024815)
1. Cell cycle dependence of sister chromatid exchange induction by DNA topoisomerase II inhibitors in Chinese hamster V79 cells. Dillehay LE; Denstman SC; Williams JR Cancer Res; 1987 Jan; 47(1):206-9. PubMed ID: 3024815 [TBL] [Abstract][Full Text] [Related]
2. Sister chromatid exchanges, chromosomal aberrations, and cytotoxicity produced by antitumor topoisomerase II inhibitors in sensitive (DC3F) and resistant (DC3F/9-OHE) Chinese hamster cells. Pommier Y; Kerrigan D; Covey JM; Kao-Shan CS; Whang-Peng J Cancer Res; 1988 Feb; 48(3):512-6. PubMed ID: 2825977 [TBL] [Abstract][Full Text] [Related]
3. Abrogation by novobiocin of cytotoxicity due to the topoisomerase II inhibitor amsacrine in Chinese hamster cells. Utsumi H; Shibuya ML; Kosaka T; Buddenbaum WE; Elkind MM Cancer Res; 1990 May; 50(9):2577-81. PubMed ID: 2158394 [TBL] [Abstract][Full Text] [Related]
4. Correlations between intercalator-induced DNA strand breaks and sister chromatid exchanges, mutations, and cytotoxicity in Chinese hamster cells. Pommier Y; Zwelling LA; Kao-Shan CS; Whang-Peng J; Bradley MO Cancer Res; 1985 Jul; 45(7):3143-9. PubMed ID: 2988762 [TBL] [Abstract][Full Text] [Related]
5. Novobiocin, nalidixic acid, etoposide, and 4'-(9-acridinylamino)methanesulfon-m-anisidide effects on G2 and mitotic Chinese hamster ovary cell progression. Rowley R; Kort L Cancer Res; 1989 Sep; 49(17):4752-7. PubMed ID: 2474373 [TBL] [Abstract][Full Text] [Related]
6. DNA double-strand break repair pathways and cellular tolerance to inhibitors of topoisomerase II. Caldecott K; Banks G; Jeggo P Cancer Res; 1990 Sep; 50(18):5778-83. PubMed ID: 2168280 [TBL] [Abstract][Full Text] [Related]
7. Differentiation of human promonocytic leukemia U-937 cells with DNA topoisomerase II inhibitors: induction of vimentin gene expression. Rius C; Zorrilla AR; CabaƱas C; Mata F; Bernabeu C; Aller P Mol Pharmacol; 1991 Apr; 39(4):442-8. PubMed ID: 1850089 [TBL] [Abstract][Full Text] [Related]
8. Application of fluorescence in situ hybridisation to study the relationship between cytotoxicity, chromosome aberrations, and changes in chromosome number after treatment with the topoisomerase II inhibitor amsacrine. Ferguson LR; Whiteside G; Holdaway KM; Baguley BC Environ Mol Mutagen; 1996; 27(4):255-62. PubMed ID: 8665870 [TBL] [Abstract][Full Text] [Related]
9. Distinct patterns of cell cycle disturbance elicited by compounds interfering with DNA topoisomerase I and II activity. Poot M; Hiller KH; Heimpel S; Hoehn H Exp Cell Res; 1995 May; 218(1):326-30. PubMed ID: 7537696 [TBL] [Abstract][Full Text] [Related]
10. Long-term inhibition of DNA synthesis and the persistence of trapped topoisomerase II complexes in determining the toxicity of the antitumor DNA intercalators mAMSA and mitoxantrone. Fox ME; Smith PJ Cancer Res; 1990 Sep; 50(18):5813-8. PubMed ID: 2168281 [TBL] [Abstract][Full Text] [Related]
11. Altered DNA topoisomerase II activity in Chinese hamster cells resistant to topoisomerase II inhibitors. Pommier Y; Kerrigan D; Schwartz RE; Swack JA; McCurdy A Cancer Res; 1986 Jun; 46(6):3075-81. PubMed ID: 3009009 [TBL] [Abstract][Full Text] [Related]
12. Topoisomerase II as a target of VM-26 and 4'-(9-acridinylamino)methanesulfon-m-aniside in atypical multidrug resistant human small cell lung carcinoma cells. de Jong S; Kooistra AJ; de Vries EG; Mulder NH; Zijlstra JG Cancer Res; 1993 Mar; 53(5):1064-71. PubMed ID: 8382551 [TBL] [Abstract][Full Text] [Related]
13. Role of topoisomerase II beta in the resistance of 9-OH-ellipticine-resistant Chinese hamster fibroblasts to topoisomerase II inhibitors. Dereuddre S; Delaporte C; Jacquemin-Sablon A Cancer Res; 1997 Oct; 57(19):4301-8. PubMed ID: 9331091 [TBL] [Abstract][Full Text] [Related]
14. Camptothecin, teniposide, or 4'-(9-acridinylamino)-3-methanesulfon-m-anisidide, but not mitoxantrone or doxorubicin, induces degradation of nuclear DNA in the S phase of HL-60 cells. Del Bino G; Darzynkiewicz Z Cancer Res; 1991 Feb; 51(4):1165-9. PubMed ID: 1997159 [TBL] [Abstract][Full Text] [Related]
15. Amsacrine-induced lesions in DNA and their modulation by novobiocin and 2,4-dinitrophenol. Shibuya ML; Buddenbaum WE; Don AL; Utsumi H; Suciu D; Kosaka T; Elkind MM Cancer Res; 1991 Jan; 51(2):573-80. PubMed ID: 1985775 [TBL] [Abstract][Full Text] [Related]
16. Mechanism of resistance of noncycling mammalian cells to 4'-(9-acridinylamino)methanesulfon-m-anisidide: comparison of uptake, metabolism, and DNA breakage in log- and plateau-phase Chinese hamster fibroblast cell cultures. Robbie MA; Baguley BC; Denny WA; Gavin JB; Wilson WR Cancer Res; 1988 Jan; 48(2):310-9. PubMed ID: 2825971 [TBL] [Abstract][Full Text] [Related]
17. [Role of topoisomerase II in the response of mammalian cells to the action of ionizing radiation. I. Change in the mitotic cell cycle of Chinese hamster CHO K1, irradiated with x-rays, after the action of novobiocin at a high concentration]. Kirillova TV; Spivak IM Tsitologiia; 1999; 41(1):53-9. PubMed ID: 10380286 [TBL] [Abstract][Full Text] [Related]
18. Structure-activity relationships of 9-anilinoacridines as inhibitors of human DNA topoisomerase II. Figgitt DP; Denny WA; Gamage SA; Ralph RK Anticancer Drug Des; 1994 Jun; 9(3):199-208. PubMed ID: 8031452 [TBL] [Abstract][Full Text] [Related]
19. [The role of topoisomerase II in mammalian cells response to ionizing radiation. II. Effect of a small concentration of novobiocin on cell cycle in x-rays irradiated HeLa cells]. Kirrilova TV Tsitologiia; 2000; 42(2):176-80. PubMed ID: 10752123 [TBL] [Abstract][Full Text] [Related]
20. Cytogenetical characterization of Chinese hamster ovary X-ray-sensitive mutant cells, xrs 5 and xrs 6. IV. Study of chromosomal aberrations and sister-chromatid exchanges by restriction endonucleases and inhibitors of DNA topoisomerase II. Darroudi F; Natarajan AT Mutat Res; 1989 Jun; 212(2):137-48. PubMed ID: 2543922 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]